Central Garden & Pet
CENT Nasdaq Household Products Financials FY2016βFY2025
Central Garden & Pet's revenue fell 2.2% to $3.1 billion in fiscal 2025. Its operating margin was 8.0%, up from 5.8% a year earlier. Free cash flow was $291 million, down 17.2%. It paid out $155 million in dividends and buybacks, 53% of free cash flow. The diluted share count fell 4.5%.
What Central Garden & Pet does
No business description yet.
- Legal name
- Central Garden & Pet Company
- Fiscal year ends
- September 27, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000887733-25-000041
0000887733
Revenue and margins
Central Garden & Pet had $3.1B of revenue in fiscal 2025, down 2.2% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 12.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $291M in fiscal 2025, 9.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Central Garden & Pet returned $155M to shareholders in fiscal 2025, 53% of free cash flow. The diluted share count fell 4.6%.
Value Central Garden & Pet yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$309M and divides by 63.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 16.8x Β· peers 14.7x Β· sector 24.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Central Garden & Pet can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $426M | $177M | $489M | $754M | $883M |
| Debt incl. finance leases | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B |
| Net debt / EBITDA | 2.3x | 3.0x | 2.3x | 1.6x | 0.9x |
| Debt / equity | 1.0x | 0.9x | 0.8x | 0.8x | 0.8x |
| Interest coverage | 4.3x | 4.5x | 3.7x | 3.2x | 4.3x |
| Current ratio | 3.0x | 3.3x | 3.7x | 3.7x | 3.7x |
| Quick ratio | 1.6x | 1.3x | 1.9x | 2.2x | 2.3x |
| Total assets | $3.1B | $3.3B | $3.4B | $3.6B | $3.6B |
| Total liabilities | $1.9B | $1.9B | $1.9B | $2.0B | $2.0B |
| Shareholders' equity | $1.2B | $1.3B | $1.5B | $1.6B | $1.6B |
| Net debt (β = net cash) | $760M | $1.0B | $700M | $437M | $309M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$1.3M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | William E BrownChairman, Director, 10% owner | Sold | 3,900 | $39.00 | $0.2M | Form 4 |
| Aug 12, 2026 | John D. Walker IIIPresident, Garden Consumer Pro | Sold | 5,000 | $39.00 | $0.2M | Form 4 |
| Aug 11, 2026 | John D. Walker IIIPresident, Garden Consumer Pro | Sold | 5,000 | $38.50 | $0.2M | Form 4 |
| Feb 19, 2026 | John RanelliDirector | Sold | 3,668 | $34.50 | $0.1M | Form 4 |
| Feb 17, 2026 | John Edward HansonPresident, Pet Consumer Prod | Sold | 5,000 | $34.75 | $0.2M | Form 4 |
| Feb 10, 2026 | Brendan DougherDirector | Sold | 3,250 | $33.38 | $0.1M | Form 4 |
| Nov 28, 2025 | Christopher T MetzDirector | Sold | 10,000 | $30.91 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 5 / 9 | 8 / 9 |
| Accruals ratio | β7.7% | β8.3% | β4.7% |
| Altman Z'' | 4.47 | 4.58 | 4.79 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Central Garden & Pet CENT | $2.8B | β2.2% | 8.0% | 9.3% | 9.7% | 16.8x | 8 | |
| Energizer ENR | $1.6B | 2.3% | β | 2.1% | 11.1% | 6.8x | 7 | Compare β |
| Spectrum Brands SPB | $1.8B | β5.2% | 4.5% | 5.9% | 5.3% | 25.2x | 6 | Compare β |
| Reynolds Consumer Products REYN | $4.9B | 0.7% | β | 8.5% | 9.9% | 14.7x | 5 | Compare β |
| Edgewell Personal Care EPC | $1.3B | β1.3% | 4.3% | 1.9% | 3.6% | β | 5 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $1.8B | $2.1B | $2.2B | $2.4B | $2.7B | $3.3B | $3.3B | $3.3B | $3.2B | $3.1B |
| Gross profit | $553M | $633M | $675M | $704M | $797M | $971M | $992M | $947M | $944M | $997M |
| Operating income | $129M | $156M | $167M | $152M | $198M | $255M | $260M | $211M | $185M | $250M |
| Interest expense | $42.8M | $28.2M | $39.2M | $42.6M | $44.0M | $58.6M | $58.3M | $57.0M | $57.5M | $57.7M |
| Pretax income | $69.6M | $126M | $127M | $119M | $154M | $195M | $199M | $162M | $142M | $217M |
| Income tax | $24.1M | $46.7M | $3.3M | $26.6M | $32.2M | $42.0M | $46.2M | $36.3M | $33.1M | $52.8M |
| Net income | $44.5M | $78.8M | $124M | $92.8M | $121M | $152M | $152M | $126M | $108M | $163M |
| Diluted EPS | $0.87 | $1.52 | $2.32 | $1.61 | $2.20 | $2.75 | $2.24 | $1.88 | $1.62 | $2.55 |
| Diluted shares | 0.05B | 0.05B | 0.05B | 0.06B | 0.05B | 0.06B | 0.07B | 0.07B | 0.07B | 0.06B |
| Cash flow | ||||||||||
| Cash from operations | $151M | $114M | $114M | $205M | $264M | $251M | β$34.0M | $382M | $395M | $333M |
| Capital expenditure | $27.6M | $44.7M | $37.8M | $31.6M | $43.1M | $80.3M | $115M | $54.0M | $43.1M | $41.4M |
| Free cash flow | $124M | $69.7M | $76.3M | $173M | $221M | $171M | β$149M | $328M | $352M | $291M |
| Depreciation and amortization | $40.0M | $42.7M | $47.2M | $50.8M | $55.4M | $74.7M | $80.9M | $87.7M | $90.8M | $84.9M |
| Stock-based compensation | $8.4M | $11.1M | $11.6M | $14.7M | $19.0M | $23.1M | $25.8M | $28.0M | $20.6M | $21.1M |
| Acquisitions | $69.0M | $104M | $91.2M | $41.2M | $0.0M | $821M | $0.0M | $0.0M | $60.2M | $3.3M |
| Share buybacks | $10.9M | $27.6M | $13.8M | $63.0M | $59.1M | $27.9M | $62.3M | $37.2M | $24.1M | $155M |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $10.9M | $27.6M | $13.8M | $63.0M | $59.1M | $27.9M | $62.3M | $37.2M | $24.1M | $155M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $93.0M | $32.4M | $482M | $498M | $653M | $426M | $177M | $489M | $754M | $883M |
| Total debt | $395M | $396M | $692M | $693M | $694M | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.2M | $0.1M | $0.0M | $0.0M | $0.3M | $0.1M |
| Current assets | $683M | $683M | $1.2B | $1.3B | $1.5B | $1.5B | $1.6B | $1.7B | $1.9B | $2.0B |
| Current liabilities | $202M | $220M | $213M | $279M | $440M | $522M | $466M | $458M | $515M | $539M |
| Inventory | $362M | $382M | $428M | $466M | $440M | $685M | $938M | $838M | $758M | $722M |
| Property and equipment, net | $158M | $181M | $218M | $245M | $245M | $329M | $397M | $392M | $379M | $363M |
| Total assets | $1.2B | $1.3B | $1.9B | $2.0B | $2.3B | $3.1B | $3.3B | $3.4B | $3.6B | $3.6B |
| Total liabilities | $626M | $670M | $954M | $1.0B | $1.3B | $1.9B | $1.9B | $1.9B | $2.0B | $2.0B |
| Shareholders' equity | $553M | $636M | $952M | $996M | $1.1B | $1.2B | $1.3B | $1.5B | $1.6B | $1.6B |
| Margins | ||||||||||
| Gross margin | 30.2% | 30.8% | 30.5% | 29.5% | 29.6% | 29.4% | 29.7% | 28.6% | 29.5% | 31.9% |
| Operating margin | 7.1% | 7.6% | 7.6% | 6.4% | 7.3% | 7.7% | 7.8% | 6.4% | 5.8% | 8.0% |
| EBITDA margin | 9.3% | 9.7% | 9.7% | 8.5% | 9.4% | 10.0% | 10.2% | 9.0% | 8.6% | 10.7% |
| Net margin | 2.4% | 3.8% | 5.6% | 3.9% | 4.5% | 4.6% | 4.6% | 3.8% | 3.4% | 5.2% |
| FCF margin | 6.8% | 3.4% | 3.4% | 7.3% | 8.2% | 5.2% | β4.5% | 9.9% | 11.0% | 9.3% |
| Returns | ||||||||||
| Return on capital | 9.9% | 10.6% | 15.1% | 10.0% | 13.5% | 12.9% | 9.2% | 7.3% | 6.9% | 9.7% |
| Return on capital employed | 13.6% | 15.1% | 12.0% | 8.8% | 10.9% | 11.3% | 9.6% | 7.3% | 6.2% | 8.2% |
| Return on equity | 8.4% | 13.3% | 15.6% | 9.5% | 11.6% | 13.2% | 11.9% | 9.0% | 7.2% | 10.4% |
| Return on assets | 3.9% | 6.3% | 7.7% | 4.7% | 5.5% | 5.6% | 4.8% | 3.8% | 3.1% | 4.5% |
| Growth | ||||||||||
| Revenue growth | 10.8% | 12.3% | 7.8% | 7.6% | 13.1% | 22.6% | 1.1% | β0.9% | β3.3% | β2.2% |
| Net income growth | 39.2% | 77.1% | 56.8% | β24.9% | 30.1% | 25.8% | 0.3% | β17.4% | β14.1% | 50.8% |
| EPS growth | 35.9% | 74.7% | 52.6% | β30.6% | 36.7% | 25.0% | β18.6% | β16.1% | β13.8% | 57.4% |
| FCF growth | 89.3% | β43.7% | 9.5% | 127.4% | 27.6% | β22.9% | β187.5% | β | 7.4% | β17.3% |
| Share count change | 2.9% | 1.5% | 2.9% | 8.0% | β5.0% | 0.9% | 23.1% | β1.8% | 0.1% | β4.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.8x | 1.8x | 1.0x | 1.0x | 0.2x | 2.3x | 3.0x | 2.3x | 1.6x | 0.9x |
| Debt / equity | 0.7x | 0.6x | 0.7x | 0.7x | 0.6x | 1.0x | 0.9x | 0.8x | 0.8x | 0.8x |
| Interest coverage | 3.0x | 5.5x | 4.3x | 3.6x | 4.5x | 4.3x | 4.5x | 3.7x | 3.2x | 4.3x |
| Current ratio | 3.4x | 3.1x | 5.7x | 4.7x | 3.5x | 3.0x | 3.3x | 3.7x | 3.7x | 3.7x |
| Quick ratio | 1.6x | 1.4x | 3.7x | 3.0x | 2.5x | 1.6x | 1.3x | 1.9x | 2.2x | 2.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 1.5% | 2.2% | 1.7% | 1.3% | 1.6% | 2.4% | 3.5% | 1.6% | 1.4% | 1.3% |
| Stock comp / revenue | 0.5% | 0.5% | 0.5% | 0.6% | 0.7% | 0.7% | 0.8% | 0.9% | 0.6% | 0.7% |
| Payouts / FCF | 8.8% | 39.6% | 18.1% | 36.3% | 26.7% | 16.4% | β | 11.3% | 6.8% | 53.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 7.0 | 7.0 | 4.0 | 4.0 | 8.0 | 5.0 | 4.0 | 6.0 | 5.0 | 8.0 |
| Altman Z'' | 4.8 | 4.7 | 5.7 | 5.5 | 5.2 | 4.1 | 4.2 | 4.5 | 4.6 | 4.8 |
| Accruals ratio | β9.4% | β2.9% | 0.6% | β5.7% | β6.6% | β3.6% | 5.8% | β7.7% | β8.3% | β4.7% |
Source: SEC EDGAR XBRL filings (CIK 0000887733). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.